Literature DB >> 31489316

Signal transducer and activator of transcriptions (STATs)-at the crossroads of obesity-linked non-alcoholic steatohepatitis and hepatocellular carcinoma.

Nivida Mishra1, Suresh Mishra2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31489316      PMCID： PMC6700019          DOI： 10.21037/hbsn.2019.03.21

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  11 in total

Review 1.  The epidemiology, pathogenesis and histopathology of fatty liver disease.

Authors:  Adam P Levene; Robert D Goldin
Journal:  Histopathology       Date:  2012-02-28       Impact factor: 5.087

2.  Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver.

Authors:  T Alonzi; D Maritano; B Gorgoni; G Rizzuto; C Libert; V Poli
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.

Authors:  Mattias Ekstedt; Hannes Hagström; Patrik Nasr; Mats Fredrikson; Per Stål; Stergios Kechagias; Rolf Hultcrantz
Journal:  Hepatology       Date:  2015-03-23       Impact factor: 17.425

4.  The influence of interoceptive awareness on functional connectivity in patients with irritable bowel syndrome.

Authors:  Mariachiara Longarzo; M Quarantelli; M Aiello; M Romano; A Del Prete; C Cimminiello; S Cocozza; G Olivo; C Loguercio; L Trojano; D Grossi
Journal:  Brain Imaging Behav       Date:  2017-08       Impact factor: 3.978

5.  Association of nonalcoholic fatty liver disease with insulin resistance.

Authors:  G Marchesini; M Brizi; A M Morselli-Labate; G Bianchi; E Bugianesi; A J McCullough; G Forlani; N Melchionda
Journal:  Am J Med       Date:  1999-11       Impact factor: 4.965

6.  Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation.

Authors:  Guobin He; Guann-Yi Yu; Vladislav Temkin; Hisanobu Ogata; Christian Kuntzen; Toshiharu Sakurai; Wolfgang Sieghart; Markus Peck-Radosavljevic; Hyam L Leffert; Michael Karin
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

7.  Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.

Authors:  Elizabeth M Brunt; Brent A Neuschwander-Tetri; Dana Oliver; Kent R Wehmeier; Bruce R Bacon
Journal:  Hum Pathol       Date:  2004-09       Impact factor: 3.466

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

Review 9.  Obesity-associated mechanisms of hepatocarcinogenesis.

Authors:  Raffi Karagozian; Zoltán Derdák; György Baffy
Journal:  Metabolism       Date:  2014-02-05       Impact factor: 8.694

10.  Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC.

Authors:  Sudharsana R Ande; K Hoa Nguyen; B L Grégoire Nyomba; Suresh Mishra
Journal:  Sci Rep       Date:  2016-03-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.